Pyramidal neurons in layer V of rodent cerebral cortex are of two main types (Larkman and Mason, 1990). One type has a thick apical dendrite extending into layer I with a prominent terminal tuft, produces distinctive initial bursts of action potentials
in response to current injection and projects out of the telencephalon to the superior colliculus, pontine nuclei
and spinal cord. The other type has a slender apical dendrite which does not reach layer I, arborises in layers II-IV without
a terminal tuft, does not burst, and projects to other cortical areas, including the contralateral hemisphere. These neurons
are generated at similar times, and with the exception of their projections, are initially indistinguishable, having tufted apical
dendrites reaching layer I and no bursting firing pattern. Towards the end of the first postnatal week the corticocortical
cells selectively lose their apical tufts (Koester and O'Leary, 1992) and it is not until 14 days postnatally that the first corticotectal cells develop the burst-firing characteristic (Kasper et al., 1994; Christophe et al., 2005). Our experiments aimed
at detecting and characterizing causal relationships between target finding, somatodendritic differentiation, physiological
specification and gene expression patterns using the different layer V projection neurons in the rodent as a model system.
Previous and recent studies have isolated molecules which serve as molecular markers for layer V neurons; Otx-
1, a transcription factor expressed in layers V/VI, specific to type I (Frantz et al., 1994; Weimann et al., 1999); SMI-32,
N200 and FNP-7 which are neurofilaments only expressed in type I neurons (Voelker et al., 2004); ER81, an ETS transcription
factor expressed in both neuronal cells types (Hevner et al., 2003; Yoneshima et al., 2005); Lmo4, a LIM domain-containing
protein known to be expressed in layers II/III and V (Bulchand et al., 2003) which is a specific marker for type
II neurons (Arlotta et al., 2005); CTIP2, a gene of unknown function specifically expressed in layer V type I neurons (Arlotta
et al., 2005).
Co-localisation studies onOtx-1 and ER81 suggested that the two markers are not expressed within the same postnatal
layer V neurons; moreover ER81 is also expressed in some type II layer V pyramidal neurons (Hevner et al., 2003;
Yoneshima et al., 2005). Although ER81 and N200 have been shown to label type I projection neurons in layer V, recent
co-localisation studies suggests that the two molecules are not co-expressed within the same cells (Rolph et al. 2005).
Retrograde labelling and immunohistochemistry for the two markers revealed that although ER81 and N200 both expressed
in type I layer V neurons, they are never coexpressed in the same projection neurons, suggesting that there are at
least two distinct neurochemical subpopulations within type I layer V pyramidal cells (Rolph, et al., 2005; A. Cheung, C.
Voelker, R. Rolph, T. Jessell and Z. Molnar unpublished observations). An important aim of these studies is to be able
to unify molecular classification with other aspects of layer V neuronal classification in adult and during development. Potential molecular markers for layer V neurons are continually being found and the correlation of these markers to other aspects
of neuronal phenotype will not only result in a more comprehensive classification of layer V projection neurons,
but also in the better understanding of the genetic and epigenetic programs of cortical neuronal differentiation and cortical
circuit formation.
ACKNOWLEDGEMENT
This work was supported by the Human Frontier Science Program (RG 107/200) and MRC.